Literature DB >> 7761686

Neuroimmunological studies in steroid-responsive meningitis-arteritis in dogs.

A Tipold1, M Vandevelde, A Zurbriggen.   

Abstract

The clinical and pathological expression of steroid-responsive meningitis-arteritis (SRMA) is predominantly neurological and the present study was therefore mostly concerned with the intrathecal humoral immune responses of 13 dogs suffering from the disease. All the dogs synthesised IgG intrathecally, indicating that the immune response in SRMA is in part specifically directed towards the central nervous system (CNS). Half of the dogs also had high levels of IgM only in the cerebrospinal fluid (CSF) and nearly all of them had high levels of IgA in the CSF as well as in the serum. Six of the dogs had circulating immune complexes in the serum, but not in the CSF. Neither IgM nor IgA rheumatoid factors were found. A chemotaxis assay revealed enhanced migration of neutrophils into the CSF in three cases. All the dogs had marked meningeal inflammation and arterial lesions of the meningeal blood vessels. Only one dog had arterial involvement outside the CNS. The acute vascular lesions consisted mostly of degenerative changes of the media and periarterial inflammation, and there was no evidence of immune complex deposition. Chronic lesions were mostly characterised by stenosis, adventitial thickening and periarteritis. Focal deposits of IgA were found in the vascular wall of one chronic case. It was concluded that the meningeal lesions in SRMA are a primary event, rather than the result of a generalised immune complex disease. These lesions are associated with an intrathecal humoral immune response, in which IgA appears to play a central role.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7761686     DOI: 10.1016/0034-5288(95)90060-8

Source DB:  PubMed          Journal:  Res Vet Sci        ISSN: 0034-5288            Impact factor:   2.534


  11 in total

1.  Clinical and clinicopathologic findings in three dogs with steroid-responsive meningitis-arteritis (SRMA).

Authors:  G Gandini; E Brini; D Bellotti; M Cipone
Journal:  Vet Res Commun       Date:  2003-09       Impact factor: 2.459

Review 2.  A review of immunologic diseases of the dog.

Authors:  N C Pedersen
Journal:  Vet Immunol Immunopathol       Date:  1999-08-02       Impact factor: 2.046

3.  Evaluating the use of cytosine arabinoside for treatment for recurrent canine steroid-responsive meningitis-arteritis.

Authors:  Christian Günther; Frank Steffen; Daniela S Alder; Laura Beatrice; Caroline Geigy; Katrin Beckmann
Journal:  Vet Rec       Date:  2020-02-21       Impact factor: 2.695

4.  Extracellular hsp70 release in canine Steroid Responsive Meningitis-Arteritis.

Authors:  Sarah A Moore; Mi Young Kim; Arianna Maiolini; Andrea Tipold; Michael J Oglesbee
Journal:  Vet Immunol Immunopathol       Date:  2011-11-02       Impact factor: 2.046

5.  A retrospective epidemiological study of clinical signs and familial predisposition associated with aseptic meningitis in the Norwegian population of Nova Scotia duck tolling retrievers born 1994-2003.

Authors:  Kristin P Anfinsen; Mette Berendt; Flora J H Liste; Therese R Haagensen; Astrid Indrebo; Frode Lingaas; Oyvind Stigen; Lis Alban
Journal:  Can J Vet Res       Date:  2008-07       Impact factor: 1.310

6.  Toll-like receptors 4 and 9 are responsible for the maintenance of the inflammatory reaction in canine steroid-responsive meningitis-arteritis, a large animal model for neutrophilic meningitis.

Authors:  Arianna Maiolini; Regina Carlson; Andrea Tipold
Journal:  J Neuroinflammation       Date:  2012-09-27       Impact factor: 8.322

7.  Evaluating the use of cytosine arabinoside for treatment for recurrent canine steroid-responsive meningitis-arteritis.

Authors:  Christian Günther; Frank Steffen; Daniela S Alder; Laura Beatrice; Caroline Geigy; Katrin Beckmann
Journal:  Vet Rec       Date:  2020-07       Impact factor: 2.695

8.  Successful surgical and medical treatment of a severe, acute epidural bleed in a young dog due to steroid responsive meningitis-arteritis.

Authors:  Jessica Zilli; Agnieszka Olszewska; Daniela Farke; Martin Jürgen Schmidt
Journal:  Acta Vet Scand       Date:  2021-07-10       Impact factor: 1.695

9.  Interleukin-6, vascular endothelial growth factor and transforming growth factor beta 1 in canine steroid responsive meningitis-arteritis.

Authors:  Arianna Maiolini; Meike Otten; Marion Hewicker-Trautwein; Regina Carlson; Andrea Tipold
Journal:  BMC Vet Res       Date:  2013-02-04       Impact factor: 2.741

10.  Treatment of canine meningoencephalomyelitis of unknown aetiology with mycophenolate mofetil and corticosteroids: 25 cases (2007-2012).

Authors:  Andrew D Woolcock; Andrea Wang; Allison Haley; Marc Kent; Kate E Creevy; Simon R Platt
Journal:  Vet Med Sci       Date:  2016-02-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.